Development and Validation of a Hypoglycemia Risk Model for Intensive Insulin Therapy in Patients with Type 2 Diabetes

Table 3

Probability and risk level of hypoglycemia based on fasting insulin, FBG, and total treatment time.

Fasting insulin (mu/L)	FBG (mmol/L)	Total treatment time (days)	Probability of hypoglycemia (%)	Risk level
≥9.30	≥7.0	<7	17	Low
≥9.30	<7.0	<7	29	Low
≥9.30	≥7.0	≥7	33	Low
<9.30	≥7.0	<7	36	Low
≥9.30	<7.0	≥7	50	High
<9.30	<7.0	<7	53	High
<9.30	≥7.0	≥7	57	High
<9.30	<7.0	≥7	73	High